Global markets stumbled on Monday, with Asian shares and U.S. futures declining sharply. The sell-off was led by a significant pullback in South Korean tech stocks amid renewed concerns over an AI sector bubble, while oil prices dropped over $2 per barrel.
Global markets opened the week under pressure, with Asian shares and U.S. futures declining amid renewed concerns over an AI sector bubble and falling commodity prices. South Korea's Kospi led losses with a sharp 4.6% drop.
Tens of thousands gathered in Prague's Wenceslas Square on Sunday, voicing support for President Petr Pavel in his escalating constitutional dispute with Prime Minister Andrej Babiš's coalition government. The protest, organized by pro-democracy activists, highlights deep divisions over Ukraine policy and a controversial ministerial appointment.
Washington has formally accused Havana of orchestrating intimidation tactics against its chief envoy, following a series of heated public confrontations that underscore escalating bilateral tensions.
Shares of the global auto parts giant have retreated nearly 8% over the past month, trading at a significant discount to industry peers. A deep dive into valuation models suggests the market may be overlooking Magna's strategic positioning in the electric vehicle supply chain.
Financial technology firm Broadridge Financial Solutions prepares to release its fourth-quarter results before Tuesday's market open, with analysts projecting modest revenue growth against a backdrop of recent sector volatility.
The brutal 2022 murder of Katlyn Lyon Montgomery, a 28-year-old mother, sent shockwaves through her Virginia community. What initially seemed a mystery was unraveled by a relentless investigation that pieced together a stalking ex-boyfriend's digital footprint, leading to a first-degree murder conviction and a life sentence.
Republican gubernatorial candidate Patrick Knight criticizes the Walz administration's approach to immigration enforcement, linking it to broader issues of governance and a recent fraud scandal, as he pitches a back-to-basics campaign platform.
Tesla's stock is navigating turbulent waters, with a recent one-day surge contrasting sharply against a weaker quarterly performance. As the EV pioneer's share price hovers above some analyst targets, investors are left weighing its ambitious robotaxi and AI-driven future against more conservative valuation models.
As Diebold Nixdorf accelerates its AI-driven self-checkout initiatives, highlighted by a new study on the Australian retail market, investors are weighing whether this technological pivot can solidify its ongoing operational turnaround and justify its current valuation.
Singapore's Venture Corporation (SGX:V03) has delivered a robust 38% total shareholder return over the past year, buoyed by dividends. However, a closer look reveals declining earnings and revenue, raising questions about the sustainability of its recent market favor and its longer-term trajectory.
Shares of materials and labeling giant Avery Dennison (NYSE: AVY) have shown resilience amid broader market swings, reigniting debate over its intrinsic value. With a significant gap between its current price and analyst targets, investors are weighing its growth in digital identification technologies against persistent sector headwinds.
With shares of the global sustainability leader up nearly 7x over three years, investors are grappling with a critical question: has the market run too far ahead of fundamentals? A deep dive into valuation metrics suggests caution may be warranted.
While Arbor Realty Trust offers shareholders clarity on favorable tax treatment for 2025 dividends, analysts remain focused on a deteriorating earnings outlook and a 'Strong Sell' rating, casting doubt on the stock's near-term prospects.
In a revealing moment during Tesla's earnings call, Elon Musk disclosed that his Saturdays are dedicated to the company's next-generation AI5 chip project, signaling a fundamental strategic shift from automaker to vertically integrated AI hardware powerhouse.
After a punishing 61% decline in its share price over the past year, Atlassian finds itself at a critical juncture. With the stock trading near $118, investors are grappling with whether this represents a profound disconnect from long-term potential or a justified reassessment of growth prospects in a shifting market.
The healthcare behemoth's robust 2025 results and 2026 guidance signal a landmark year ahead, as it navigates patent expirations and pricing pressures while maintaining its coveted dividend king status.
As earnings season unfolds, Apple and Meta Platforms both posted impressive results, but their paths diverge sharply. Apple's growth reaccelerates on iPhone strength, while Meta's robust outlook is shadowed by soaring AI investments. The debate over which stock offers the better value is heating up.
Despite a robust drug pipeline and steady long-term gains, AstraZeneca's recent share price stagnation has investors questioning its true worth. A deep dive into valuation models suggests the pharmaceutical giant may be trading at a significant discount to its intrinsic value, even as its P/E ratio appears elevated compared to peers.
A wave of analyst upgrades for Applied Materials underscores growing confidence in global semiconductor capital expenditure, driven by the AI infrastructure boom and demand for advanced manufacturing tools. The company's strategic position in wafer fabrication equipment places it at the heart of the industry's next growth phase.
